Reply
Christophe Bureau, Jean‐Pierre Vinel – 9 December 2013
T‐cell Ig and ITIM domain regulates natural killer cell activation in murine acute viral hepatitis
Jiacheng Bi, Qing Zhang, Dan Liang, Lei Xiong, Haiming Wei, Rui Sun, Zhigang Tian – 9 December 2013 – Uncontrolled natural killer (NK) cell activation during the early response to acute viral infection can lead to severe immunopathology, and the mechanisms NK cells use to achieve self‐tolerance in such contexts are currently unclear. Here, NK cells up‐regulated a coinhibitory receptor, T‐cell Ig and ITIM domain (TIGIT), during challenge with the viral double‐stranded RNA (dsRNA) analog poly I:C.
Diagnosis of minimal hepatic encephalopathy in patients with cirrhosis: Should we bury psychometric tests?
Dominique Thabut, Kiyoka Kinugawa, Nicolas Weiss – 9 December 2013
Vitamin D levels in patients with chronic hepatitis B
Cumali Efe, Tugrul Purnak, Ersan Ozaslan – 6 December 2013
Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell‐cycle control and apoptosis
Ulrike A. Köhler, Svitlana Kurinna, Dominik Schwitter, Andrea Marti, Matthias Schäfer, Claus Hellerbrand, Tobias Speicher, Sabine Werner – 6 December 2013 – The nuclear factor erythroid‐derived 2, like 2 (Nrf2) transcription factor is a key regulator of the antioxidant defense system, and pharmacological activation of Nrf2 is a promising strategy for prevention of toxin‐induced liver damage. However, the consequences of Nrf2 activation on liver regeneration (LR) have not been determined.
Reply
Chiun Hsu, Pei‐Jer Chen, Ann‐Lii Cheng – 6 December 2013
Looking into the crystal ball: The 60‐5 criterion—a newly proposed predictor of severe complications after liver transplantation
Jay A. Graham, James V. Guarrera – 4 December 2013
Type I and type III interferon‐induced immune response: It's a matter of kinetics and magnitude
David Olagnier, John Hiscott – 4 December 2013
The times they are a‐changin'
Nedim Hadžić, Roshni Vara – 29 November 2013